Loading...

SRPT SAREPTA THERAPEUTICS INC Earnings Reports 8-K Filing

SRPT

SRPT

SAREPTA THERAPEUTICS INC

(SRPT)

2024 8-K

Show Summary

Show Summary

Rights Offerings

Earnings Announcement

Credit Agreement

Financial Results

Collaboration Agreement

Amendment to Incentive Plan

Financial Results

FDA Approval of ELEVIDYS

Annual Meeting Results

External Links:

Sarepta Therapeutics disclosed preliminary financial information for the year ended December 31, 2023, including a cash position of $1.7 billion and $1.145 billion in total net product revenue.

AI Assistant

SAREPTA THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.